Regenerative Medicine Industrialization Task Force (RMIT)
日本語
Fostering Regenerative Medicine Development in Japan / Regenerative Medicine Industrialization Task Force (RMIT)
News

About RMIT

About us

Regenerative Medicine Industrialization Task Force (RMIT) has been established as a task force under Forum for Innovative Regenerative Medicine (FIRM).
Objectives :
Japan has set up the most advanced legal and regulatory environment for industrialization of regenerative medicine and cell therapy since the progressive legislations that took place in the autumn of 2014. Encouraged by that, some of the FIRM member companies have volunteered to organize Regenerative Medicine Industrialization Task Force (RMIT) and organized an industrialization support team as its initiating activity.
This support team is meant to help wide spectrum of organizations such as established mega pharmas, emerging venture businesses, or thriving academia, domestic and overseas alike, resolving various bottlenecks that hinder prompt industrialization of regenerative medicine and cell therapy. Our ultimate goal is to serve patients who crave break-through therapies by accelerating application of the stateof-the-art medical technologies.

Activities

Consultation Service for the Industrialization of Regenerative Medicine at Nihonbashi Business Base

With respect to industrialization of regenerative medicine and cell therapy, our support team will provide responses to the following requests and inquiries.
Upon necessity, we support and connect clients to relevant FIRM member companies for them to collaborate to further tackle the problems.
The services provided by the support team are principally free of charge for the time being.

 1) Inquiries on regulatory issues
 2) Inquiries on procurement, purchase, or trial use of materials, consumables and/or equipment
 3) Inquiries on procurement, purchase, or trial use of apparatuses, machines, and/or facility
 4) Inquiries and/or requests relating to manufacture and quality assurance
 5) Inquiries relating to clinical studies
 6) Inquiries relating to clinical trials
 7) Inquiries around application and commercialization of products, e.g., excellent medical clinics for collaboration
 8) Requests and/or inquiries with any other aspects concerning industrialization of regenerative medicine and cell therapy

Framework of Preparing an Industrialization Demonstrating Site

With the aim of the rapid pipeline commercialization of cellular and tissue-based products in regenerative medicine inside and outside of Japan, the construction of a system providing research support, services and response/request to consultation etc. is being promoted to allow for one-stop service from research and development to clinical trials in Tonomachi, Kawasaki City, which is the International Strategic Zone of Kanagawa Prefecture.

Access

E-mail correspondence is encouraged for oversea clients due to the time difference. If you prefer to call us, our lines are open from 0900 to 1200 and 1300 to 1600 Japan Standard Time, Monday through Friday.

E-mail        info-tf@firm.or.jp
Phone:       +81 3 3510 9621 (English) +81 3 3510 9620 (Japanese)

DISCLAIMER OF WARRANTY

Regenerative Medicine Industrialization Task Force (RMIT) established in Forum for Innovative Regenerative Medicine (FIRM) will provide referral and information provision services in order to facilitate commercialization of regenerative medicine (the “Services”).
TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, THE SERVICES ARE PROVIDED ON “AS AVAILABLE” AND “WITH ALL FAULTS” BASIS AND PROVIDED WITHOUT WARRANTIES, CONDITIONS, REPRESENTATIONS OR GUARANTIES OF ANY KIND, EITHER EXPRESSED, IMPLIED, STATUTORY OR OTHERWISE, INCLUDING, BUT NOT LIMITED TO, ANY IMPLIED WARRANTIES OR CONDITIONS OF MERCHANTABILITY, SATISFACTORY QUALITY, CORRECTNESS, COMPLETENESS, NONINFRINGEMENT OF ANY PARTY’S RIGHT OR FITNESS FOR A PARTICULAR PURPOSE. NO ORAL OR WRITTEN INFORMATION OR ADVICE GIVEN BY RMIT SHALL CREATE A WARRANTY.
After the provision of the Services, RMIT shall not be responsible for any process or result in discussion or negotiation between you and any referred party.

Member

Access

RMIT Office

2-3-11, Nihonbashi Lifescience Building 6F, Nihonbashi-Honcho, Chuo-ku, Tokyo 103-0023, Japan
TEL : +81-3-3510-9621 (English)

 ・About 3-minute walk from Exit A6 of Mitsukoshi-Mae Station on Tokyo Metro Ginza Line/Hanzomon Line
 ・3-minute walk from Exit 5 of Shin-Nihonbashi Station on JR Sobu Line
 ・15-minute walk from East Exit of Kanda Station on JR Yamanote Line, Keihin-Tohoku Line, Chuo Line

Faq

What are missions of RMIT? What is its relationship with FIRM?
To facilitate prompt industrialization of regenerative medicine and cell therapy, RMIT responds to the requests and inquiries of pharmaceutical companies, venture businesses, and academic institutions, domestic and overseas alike, to help resolve various bottlenecks. Through these activities, we strive to serve patients awaiting novel, ground-breaking treatments by accelerating application of state-of-the-art medical technologies.
RMIT is a task force comprising several volunteer companies affiliated with FIRM (Forum for Innovative Regenerative Medicine, General Incorporated Association).
Is RMIT a public organization?
No, it is not a public organization but rather a task force organized within FIRM.
How can I contact RMIT and submit an inquiry?
Please fill out the contact form on our website. While we can respond to phone calls during business hours, we recommend you contact us via e-mail.
Will I be charged if I ask RMIT to provide services such as partnering assistance?
All services are free of charge for the time being.
Are there any limits on choices of potential matching partners?
RMIT will evaluate your compatibility with FIRM member companies as potential partners
Can you guarantee to find a matching partner candidate if I ask one?
No; we cannot make such a guarantee, as we may not be able to match you successfully. At the other extreme, you may be matched with multiple partner candidates.
Can I expect RMIT to intervene and mediate if troubles occur during the partnering negotiation?
RMIT only introduces partner candidates to you. Activities such as partnering negotiation and contract engagement must be duly handled by and between the parties directly involved (Disclaimer of Warranty).
Does RMIT offer financial support?
Unfortunately no, we don't offer financial support.
Can I visit your office, which is shown on your website, for a face-to-face meeting?
While we may arrange a meeting in our office during the course of our interactions, we request that you use e-mail as the primary contact method.
Can I get your brochure?
Sure; please consult the PDF files available at the following link: (link)
English and Japanese versions are available.
I see that phone numbers are listed for English and Japanese speakers; do you offer services in languages other than English and Japanese?
We can only discuss issues in English and Japanese at the moment.

Contact

E-mail correspondence using contact form below is encouraged for oversea clients due to the time difference.
If you prefer to call us, our lines are open from 0900 to 1200 and 1300 to 1600 Japan Standard Time, Monday through Friday.
E-mail        info-tf@firm.or.jp
Phone:        +81 3 3510 9621 (English)

Contact Form

Please fill in each items and send us mail by click the accept bottom. We will reach out to you by mail in three business days.

Name Must First Name   Last Name
Email Must
Phone Must Country Code   Number
Cell Phone Voluntary Country Code   Number
Organization Must
URL Voluntary
Business/Research Field voluntary
Department Voluntary
Title Voluntary
Country Must
City Voluntary
Contents of Inquiry/Request  
 Categories (Multiple Choices) Must
 Partnering Must
 Contents Details Must
COPYRIGHT (c) Forum for Innovative Regenerative Medicine ALL RIGHTS RESERVED.